Tenon Gets US FDA Clearance of Catamaran for New Indication

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Tenon Gets US FDA Clearance of Catamaran for New Indication

, MT Newswires - 4:57 PM ET 3/24/2025 default

04:57 PM EDT, 03/24/2025 (MT Newswires) -- Tenon Medical ( TNON ) said late Monday the US Food and Drug Administration has cleared an expanded indication for its Catamaran SI Joint Fusion System for use in augmenting thoracolumbar fusion.

The Catamaran is now indicated to treat the sacroiliac joint as a stand-alone treatment or to augment a spinal fusion, Tenon said.

The shares were rising over 40% in recent after-hours activity.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.